Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
20 a » 20 _ (Expand Search), 20 μ (Expand Search), 20 c (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
20 a » 20 _ (Expand Search), 20 μ (Expand Search), 20 c (Expand Search)
-
321
-
322
-
323
-
324
OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts.
Published 2019“…However, co-treatment of OCA with Gemcitabine or Cisplatin resulted in a tumor volume significantly lower compared to Gemcitabine or Cisplatin alone (p < 0.05). Means ± SE of N = 5 for each group. * p < 0.05 vs controls, <sup>&</sup> p < 0.05 vs OCA, <sup>¤</sup> p < 0.05 vs Cisplatin alone, <sup>§</sup> p < 0.05 vs Gemcitabine alone. …”
-
325
-
326
-
327
-
328
-
329
-
330
-
331
-
332
-
333
-
334
Results of subjective and objective SE in photopic and twilight and AA are shown.
Published 2022Subjects: -
335
-
336
-
337
-
338
-
339
Nilotinib decreases HEI-193 cell viability in a time-, dose-, and growth condition- dependent manner.
Published 2013“…(B) HEI-193 grown in PDGF media were treated with 0, 3, 5, 10 or 20 µM nilotinib up to 5 days. Trypan blue viability assay shows decreased number of viable cells at 5 days in 3 µM nilotinib, compared to vehicle shown, mean and SD of six technical replicates. …”
-
340